Found: 109
ОБЗОР2026 · pp. 79–86
Ivanova E.I., Chernyshova A.L., Sisakyan V.G., Tamkovich S.N.
Relevance. PARP inhibitors (PARPi), have emerged as a significant development in the treatment of high-grade serous ovarian cancer that is associated with mutations in BRCA1/2 and genes of other homologous recombination proteins. These drugs exploit synthetic …
ОБЗОР2026 · pp. 75–83
Aselderova A.I., Magaramov A.M., Huseynov A.G., Yuzbekov G.D.E., Merzlenko D.D., Yusupova E.A., Musaeva P.R.
Relevance. Modern approaches to detecting circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) demonstrate high potential for improving the accuracy of molecular diagnostics of tumors and require a comprehensive analysis of all stages, from the biology of f…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 52–56
Kaigorodova E.V., Kovalеv O.I., Grishchenko M.Y., Tulendinov E.R.
Introduction. Ovarian cancer is characterized by high mortality. Despite available diagnostic and therapeutic methods, patient survival remains unsatisfactory, especially for high-grade tumors, necessitating the exploration of new molecular targets. Heat shock…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 21–30
Guseva K.A., Paltsev A.A., Mitrofanova L.B.
Introduction. Adenomas are the most common disease affecting the pituitary gland. Most of these tumors can be successfully treated. The main method is transsphenoidal resection. The exception is prolactinomas, which are treated with dopamine agonists. Objectiv…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 71–77
Asanova E.R., Maksimova P.E., Zima D.V., Khabarov O.R., Fedotov V.V., Zayblitskaya E.Yu.
Introduction. Due to the rapidly growing incidence of tumor pathology of the thyroid gland, the range of molecular genetic research methods used to study the targets of targeted drugs, prognosis and surgical tactics is growing. Aim. To study the frequency of m…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 56–64
Mitrofanova L.B., Makarov I.A., Guseva K.A., Danilova I.A., Gulyaev D.A.
Introduction. The pathogenesis of infection of the central nervous system (CNS) with SARS-CoV2 and nervourological complications are still poorly understood, as well as the link of viral infection with the risk and the course of gliomas. The aim. Evaluating of…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 68–74
Mikashinovich Z.I., Telesmanich N.R., Smirnova O.B.
Introduction. In clinical experiments with various pathologies leading to the activation of POL, it was found that one of the most important areas of correction of oxidative stress is the use of drugs with the properties of antioxidants and antihypoxants [6, 7…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 40–47
Merkureva O.N., Kuznetsov I.N., Babkina I.V., Rogozhin D.V., Sushentsov E.A., Gershtein E.S., Kushlinskii N.E.
Introduction. Angiogenesis regulators are of particular interest as new serum markers in cancer patients, since they reflect the intensity of tumor growth and metastasis. Currently, many works are dedicated to the study of vascular endothelial growth factor (V…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 28–33
Novak-Bobarykina U.A., Dokhov M.A., Krylova Yu.S., Kvetnaya T.V., Paltsev M.A.
Relevance. Ectopic secretion, which occurs in the early stages of tumor development, is not only one of the first signs of a neoplasm, but can also indicate the severity of the oncological process. Purpose of the study: To evaluate the possibility of using the…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 22–26
Hop Do Ngoc, Mironova E.S., Kvetnoy I.M., Dokhov M.A., Paltsev M.A.
Introduction. Lung carcinoma is one of the most common cancers and the most likely cause of cancer mortality in the world. The use of the IHC method to determine the immunophenotype of tumor cells greatly facilitates the differential diagnostic search, allows …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 25–32
Kudriashov G.G., Vinogradova T.I., Zmitrichenko Yu.G., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Gavrilov P.V., Azarov A.A., Tochilnikov G.V., Nefedov A.O., Krylova Yu.S., Yablonskii P.K.
Introduction. Lung cancer and tuberculosis, make a significant affect to the morbidity and mortality of the population in Russia and in the world. Strategy of medication therapy has not been developed for cases when these diseases are combined. The aim of the …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 25–32
Gershtein E.S., Kuzmin Yu.B., Alferov A.A., Korotkova E.A., Tsarapaev P.V., Sokolov N.Yu., Kuznetsov I.N., Vashketova O.I., Kozlova E.M., Yanushevich O.O., Boulytcheva I.V., Stilidi I.S., Kushlinskii N.E.
Background. Low sensitivity of bone tumors to various schemes of standard chemotherapy stimulated the search of new targets for their medicamentous treatment. Among such targets are the so-called “immune checkpoints” promoting the escape of the tumor from the …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 28–34
Kovaleva O.V., Zybina N.N., Gratchev A.N., Chang V.L., Ognerubov N.A., Stilidi I.S., Kushlinskii N.E.
Introduction. Stomach cancer in Russia occupies the 4th place among most frequent malignant neoplasms, after tumors of the lung, breast and colon. The search for new diagnostic and prognostic markers of this pathology is an urgent task of modern molecular onco…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 34–40
Koroleva E.I., Musaelyan A.A., Nazarov V.D., Lapin S.V., Vorobev S.L., Sharova O.L., Kozorezova E.S., Korablina I.M., Emanuel V.L., Orlov S.V.
Introduction. In 2013 The Cancer Genome Atlas research group divided the molecular aberrations in endometrial cancer into four subtypes: POLE mutations, microsatellite instability, copy-number low and copy-number high. These subtypes have different prognosis a…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 60–64
Chetveryakov A.V., Tsepelev V.L.
Background. Protein 4-1BB (CD137) enhances the activity of T-cells, prevents their death, and promotes the production of cytokines, which makes it a powerful co-stimulating agent. Currently, the use of this glycoprotein is being studied in order to influence t…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022
Palkina N.V., Zemtsov D.S., Narkevich A.N., Bardetskaya Ya.V., Kirichenko A.K., Ruksha T.G.
Pre-metastatic niche formation precedes tumor dissemination although the mechanisms of it remain unclear. Therefore, the aim of the study was to evaluate the expression of molecules characterizing the microenvironment remodeling in target organs lungs and live…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021
Tsyrenzhapova S.V., Belonogov R.N., Sergeeva E.Y., Ruksha T.G.
Introduction. Early diagnostics of such oncological disease as cutaneous malignant melanoma is strictly important for the decrease of mortality. It is known that microRNA expression in melanoma cells and in bening melanocytic nevi is different, that can be use…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021
Bragina O.D., Chernov V.I., Larkina M.S., Stasyuk E.S., Zelchan R.V., Medvedeva A.A., Garbukov E.Yu., Vernadskyi R.Yu., Deev S.M., Tolmachev V.M.
Introduction. The main attention of researchers is paid to the study of one of the members of the EGF family – the receptor of epidermal growth factor 2 (Her2/neu), the overexpression of which is detected in 15–20% of cases of invasive breast cancer and had an…
ОБЗОР2021
Mironova E.S., Novak-Bobarykina U.A., Pal’cev M.A., Yablonskiy P.K., Sokolovich E.G., Kvetnoy I.M.
Lung cancer occupies the leading position in at the structure of oncological morbidity in the developed countries. The overall five-year survival rate for lung cancer isn’t exceed to 10–20% even using of the entire modern arsenal of therapeutic methods. Multip…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Galkovsky B.E., Mitrofanova L.B., Gulyaev D.A. Lakhina Y. S., Osipov Y.S.
Currently, glioblastoma is an extremely malignant tumor, for which treatment only temozolomide is relatively effective. Aim to study the expression and variants of coexpression of transcription factors NeuroD1, Prox1, FoxM1, somatostatin receptors of the 2nd a…